For central nervous system (CNS) applications, attempts are being made to deliver AAV gene therapy directly to the brain parenchyma or the cerebrospinal fluid (CSF) space by intra-cisterna magna ...

One strategy converts mammalian cells into ‘packaging cells’ by genetically modifying them to express the AAV genes rep and cap, which help copy and package viral genetic material. For gene ...